MetLife (MET) has faced certain fluctuations in valuation and shareholder returns, particularly after recent share price weakness and price movement.
Wells Fargo and UBS have given a price target of $92.00 and $95.00 respectively to the company, while several investors have bought and sold considerable shares. The company has beaten Q3 2025 earnings estimates with an EPS of $2.37 but was short in revenue with $17.36 billion against Wall Street projections.
Investment income and lower costs in the Asia unit have been the driver of its Q3 earnings, while derivatives losses have negatively impacted its revenue.
MetLife's valuation assessment remains mixed due to varied share price trends. However, robust earnings indicate the potential for growth and strategic focus in its operations. The company's digital expansion and improved annuity access through Alight Worklife Integration mark significant steps in its growth paradigm. Notwithstanding, Q1 earnings and Q2 revenues were disappointing, missing estimates and resulting in a share drop. Significant transactions have occurred with its shares, and following its Q3 2025 earnings, the outlook remains cautiously optimistic.
Metlife MET News Analytics from Mon, 31 Mar 2025 07:00:00 GMT to Sat, 08 Nov 2025 18:54:44 GMT -
